Stay updated on Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.
Latest updates to the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check15 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has removed a detailed section regarding data download options and fields related to clinical studies, which may affect users looking for specific study information.SummaryDifference14%
- Check44 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options for data in various formats (CSV, JSON, RIS, FHIR) and allowing users to select specific fields for download.SummaryDifference16%
- Check51 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.3%
- Check58 days agoChange DetectedThe website has been updated to version 2.12.0 on October 23, 2024, following the removal of version 2.11.2 from June 26, 2024.SummaryDifference1%
Stay in the know with updates to Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.